2026 Medicare Negotiated Drug Prices Are Now in Effect: What Changed for Common Part D Medications

2026 Medicare negotiated drug prices are now in effect for the first group of selected Medicare Part D medications, and many beneficiaries are asking a practical question: “How much will my prescriptions cost now?” The answer depends on more than the new federal price. Your Part D plan’s formulary, pharmacy network, deductible, copays, and total annual drug costs still matter.

What are 2026 Medicare negotiated drug prices and how do they affect what you pay?

The 2026 Medicare negotiated drug prices are officially called Medicare Maximum Fair Prices, created under the Inflation Reduction Act. According to the Centers for Medicare & Medicaid Services, the first negotiated prices apply beginning January 1, 2026, for selected high-spend Medicare Part D drugs.

These prices set a maximum amount that participating drug manufacturers may charge Medicare Part D plans and eligible beneficiaries for the selected drugs. In plain language, the government-negotiated price lowers the pricing benchmark for certain medications, but it does not mean every Medicare beneficiary will see the same pharmacy receipt.

Your actual cost can still vary because Part D plans are private insurance plans approved by Medicare. Each plan can have different premiums, preferred pharmacies, drug tiers, utilization rules, and pharmacy contracts.

CMS and the U.S. Department of Health and Human Services announced in 2024 that, if the negotiated prices had been in effect in 2023, Medicare would have saved an estimated $6 billion on the selected drugs, and beneficiaries were projected to save an estimated $1.5 billion in out-of-pocket costs in 2026. Those are national estimates, not a guarantee for any one person’s medication list.

Which drugs have 2026 Medicare negotiated drug prices?

The first group of 2026 Medicare negotiated drug prices applies to 10 Medicare Part D drugs selected by CMS for initial price applicability year 2026. These medications are commonly used for conditions such as diabetes, heart failure, blood clots, autoimmune disease, and certain cancers.

According to CMS’s “Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026,” the selected drugs and maximum fair prices for a 30-day equivalent supply include:

• Eliquis — $231 for a 30-day equivalent supply
• Jardiance — $197 for a 30-day equivalent supply
• Xarelto — $197 for a 30-day equivalent supply
• Januvia — $113 for a 30-day equivalent supply
• Farxiga — $178.50 for a 30-day equivalent supply
• Entresto — $295 for a 30-day equivalent supply
• Enbrel — $2,355 for a 30-day equivalent supply
• Imbruvica — $9,319 for a 30-day equivalent supply
• Stelara — $4,695 for a 30-day equivalent supply
• Fiasp and NovoLog insulin products — $119 for a 30-day equivalent supply

These are not necessarily the same as your copay. For example, if your plan charges a fixed copay for a drug, your pharmacy cost may be lower than the maximum fair price. If your plan uses coinsurance, the negotiated price can have a more direct effect because your share is usually calculated as a percentage of the drug’s plan-recognized cost.

How much will Medicare Part D drugs cost in 2026 after negotiated prices?

For many beneficiaries, the best way to estimate 2026 prescription costs is to calculate total annual drug cost, not just the price of one medicine. Total annual cost includes monthly plan premiums, deductibles, copays, coinsurance, and the pharmacy you use.

Here is a simple way to think about the cost:

• Monthly premium: What you pay to keep the Part D plan, whether or not you fill a prescription.
• Annual deductible: The amount you may pay before the plan begins sharing costs, depending on the drug tier.
• Copay or coinsurance: Your cost at the pharmacy after the plan’s rules are applied.
• Pharmacy pricing: Preferred pharmacies may cost less than standard network pharmacies.
• Annual out-of-pocket limit: Medicare Part D has an annual cap on covered prescription drug out-of-pocket spending, which changes the cost exposure for people taking high-cost medications.

For example, a Florida retiree taking Eliquis may see lower underlying plan costs because Eliquis is one of the drugs with a 2026 Medicare negotiated price. But if one plan places Eliquis on a preferred brand tier with a lower copay and another plan uses higher coinsurance or has a less favorable preferred pharmacy arrangement, the annual cost can still differ significantly.

Someone taking Stelara or Imbruvica may be more affected by the Part D out-of-pocket cap and plan formulary structure than by a single monthly pharmacy price. For high-cost specialty medications, the key question is often how quickly you reach the annual out-of-pocket threshold and whether the drug is covered with prior authorization or other restrictions.

Why won’t every Medicare plan produce the same savings?

It is a common mistake to assume that 2026 Medicare negotiated drug prices automatically make every Part D plan equally affordable. The maximum fair price affects the selected drug’s pricing, but each Part D plan still designs its own formulary within Medicare rules.

The formulary is the plan’s list of covered drugs. Two plans can both cover Jardiance, for example, but place it on different tiers or apply different cost-sharing rules.

Plan differences may include:

• Drug tier: Preferred brand, non-preferred brand, or specialty tier placement can change your cost.
• Deductible treatment: Some drugs may be subject to the deductible, while others may have first-dollar coverage.
• Prior authorization: The plan may require your doctor to confirm medical necessity before coverage applies.
• Step therapy: The plan may require you to try another medication first, if clinically appropriate.
• Quantity limits: The plan may limit how much medication can be filled at one time.
• Preferred pharmacy network: A drug may cost less at one pharmacy than another, even under the same plan.

This is why licensed Medicare advisors often run a full medication comparison instead of simply checking whether a drug appears on a plan list. At Core Insurance Solutions, plan reviews typically focus on the complete cost picture: prescriptions, pharmacies, premiums, formularies, and expected annual spending.

What should you compare before choosing a 2026 Medicare Part D plan?

Before choosing coverage, compare your medications against each plan’s 2026 formulary and pharmacy pricing. Medicare’s Annual Enrollment Period generally runs from October 15 through December 7 each year, with changes effective January 1, so beneficiaries should review plans before the new year begins.

Start with your exact medication list. Include drug name, dosage, frequency, quantity, and whether you use a local pharmacy, mail order, or both.

Then compare:

• Is the drug covered? Confirm each medication appears on the 2026 formulary.
• What tier is it on? A lower tier can mean lower copays, but not always.
• Does the deductible apply? A low-premium plan with a high deductible may cost more for some people.
• Which pharmacy is preferred? The same drug can price differently at CVS, Walgreens, Walmart, Publix, Costco, mail order, or an independent pharmacy.
• Are there restrictions? Prior authorization, quantity limits, and step therapy can affect access.
• What is the estimated annual cost? Focus on the full year, not only the January refill.

For caregivers helping a parent, this step is especially important. A parent may say, “My drug price went down,” but the plan could still have a higher premium, a non-preferred pharmacy arrangement, or restrictions that make the total annual cost higher than expected.

How do 2026 Medicare negotiated drug prices interact with the Part D out-of-pocket cap?

The 2026 Medicare negotiated drug prices are only one part of the larger Medicare Part D redesign. The Inflation Reduction Act also changed how beneficiaries move through Part D cost phases and limited annual out-of-pocket exposure for covered Part D drugs.

CMS set the 2026 Medicare Part D annual out-of-pocket threshold at $2,100 for covered Part D drugs. This means many people taking expensive covered medications may have more predictable annual drug spending than they did under the older Part D structure.

However, the cap does not mean every prescription is free after January. You may still pay premiums, and the cap applies only to covered Part D drug out-of-pocket costs that count under Medicare rules.

This is one reason the annual cost estimate matters. A person taking only one selected medication may benefit from a lower negotiated price but never reach the out-of-pocket cap, while another person taking multiple high-cost medications may reach the cap earlier in the year.

What are realistic 2026 cost examples for Medicare beneficiaries?

Because plan designs vary, the following examples are practical scenarios rather than universal quotes. They show why 2026 Medicare negotiated drug prices should be reviewed alongside the full Part D plan structure.

Consider a beneficiary taking Eliquis and two low-cost generics. If Plan A has a higher monthly premium but a lower Eliquis copay at the beneficiary’s preferred pharmacy, it may cost less over the year than Plan B with a cheaper premium and higher pharmacy charges.

Now consider someone taking Jardiance, Entresto, and several generics. Even with negotiated pricing on selected brand-name drugs, the person should compare whether both drugs are on favorable tiers, whether the deductible applies, and whether their local pharmacy is preferred.

A third example is a beneficiary taking Stelara. The drug’s maximum fair price is still high compared with many common medications, so the person’s annual cost may be shaped heavily by specialty-tier rules, prior authorization, and the Part D out-of-pocket cap.

In real plan reviews, the “cheapest” plan is rarely determined by premium alone. For people with ongoing prescriptions, the better question is: Which plan gives me the lowest predictable annual cost while covering my drugs at a pharmacy I can actually use?

Do Medicare Advantage plans use the same negotiated drug prices?

Many Medicare Advantage plans include Part D prescription drug coverage, often called MAPD coverage. If the plan includes Part D benefits, the negotiated drug pricing rules for selected Part D medications can apply within that prescription drug benefit.

However, Medicare Advantage members should still compare the entire plan, not just prescription costs. Medical copays, provider networks, referrals, dental, vision, hearing benefits, and maximum out-of-pocket limits can all affect whether a plan is a good fit.

For Florida beneficiaries, this can be especially important because Medicare Advantage plan availability varies by county. A plan available in Tampa may not be available in the same form in Naples, Orlando, Jacksonville, Fort Myers, or Miami.

If you use a specific cardiologist, endocrinologist, rheumatologist, oncologist, or preferred hospital system, make sure the medical network and prescription formulary both work for you. A low drug estimate is not helpful if your doctors or pharmacies are out of network.

How much does it cost to get help comparing 2026 Medicare drug plans?

Many beneficiaries use Medicare.gov’s Plan Finder at no cost. This is an official CMS tool and can be very helpful when your medication list is accurate and you understand how to compare annual costs, pharmacy networks, and plan restrictions.

Working with a licensed Medicare insurance professional often has no direct advisory fee to the beneficiary when the advisor is compensated by insurance carriers for enrollments, where permitted by law and carrier appointment rules. You should always ask how the advisor is compensated and whether they represent multiple carriers.

The value of professional help is not just entering drug names into software. A knowledgeable advisor can help check whether a plan covers your medications, whether your preferred pharmacy is cost-effective, and whether a Medicare Advantage or standalone Part D option better fits your situation.

Core Insurance Solutions is a Florida health insurance and senior benefits advisory that works with Medicare beneficiaries, retirees, and caregivers who need clear guidance. Our licensed insurance professionals use CMS resources, plan formularies, Evidence of Coverage documents, and carrier materials to help clients compare options carefully.

What steps should you take before relying on 2026 Medicare negotiated drug prices?

Before you assume your medications will automatically be cheaper, take a step-by-step approach. This helps avoid surprises at the pharmacy counter and gives you a more realistic view of your annual prescription budget.

• List every medication: Include brand names, generics, dosage, frequency, and quantity.
• Confirm which drugs are selected: Check whether any of your medications are part of the 2026 negotiated price list.
• Compare multiple plans: Do not assume your current plan remains the lowest-cost option.
• Check pharmacy options: Compare your current pharmacy with preferred retail and mail-order choices.
• Review restrictions: Look for prior authorization, step therapy, and quantity limits.
• Calculate annual cost: Include premiums, deductible, copays, coinsurance, and expected refill timing.

Also remember that drug lists and plan pricing can change from year to year. Medicare beneficiaries should review their Annual Notice of Change and compare coverage every fall, especially when taking brand-name or specialty medications.

How can Core Insurance Solutions help you compare 2026 Medicare negotiated drug prices?

The new 2026 Medicare negotiated drug prices may lower costs for many people, but they do not remove the need to compare Part D plans carefully. The right plan depends on your medications, pharmacy, county, doctors, budget, and whether you prefer Original Medicare with a standalone Part D plan or a Medicare Advantage plan with drug coverage.

If you are unsure whether your prescriptions will cost less in 2026, Core Insurance Solutions can help you review your medication list, compare formularies, check pharmacy tiers, and estimate annual drug costs before you enroll. Visit https://coreforseniors.com to connect with a knowledgeable Medicare advisor and get step-by-step guidance for your situation.

This article is for informational purposes only and does not constitute financial advice. Consult a qualified professional for your specific situation.